Literature DB >> 4042883

[Hyperprolactinemia and prolactinomas. Results of surgical and drug therapy].

G Brabant, I Brennecke, H Herrmann, H Friedrich, T O Wagner, A von zur Mühlen, R D Hesch.   

Abstract

185 patients with hyperprolactinaemia and prolactinoma were evaluated in a retrospective investigation. 128 patients were treated surgically whereby the prolactin serum level in 47% of the macroprolactinoma and 60% of the microprolactinoma patients was normalised (prolactin less than 25 ng/ml, no radiological evidence of tumor). Of those patients in whom the operation was less successful, a normal prolactin level could be achieved in 77% by additional therapy with dopamine agonists. Of 57 patients handled exclusively with drugs, the prolactin level was normalised by dopamine agonists in 78%. A small number of patients from both groups did not show a satisfactory fall in the prolactin level despite the use of markedly higher doses of dopamine agonists. During dopamine agonist therapy progressive tumor enlargement was detected radiologically in a previously operated patient.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042883     DOI: 10.1055/s-2008-1069047

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  1 in total

1.  Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma.

Authors:  G Hildebrandt; J Zierski; P Christophis; A Laun; H Schatz; I Lancranjan; N Klug
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.